Table II.

Reported cutaneous manifestations of SARS-CoV-2 infection and most commonly reported cutaneous manifestations of COVID-19 vaccines

Dermatologic description in categories	Associated with COVID-19 infection	Associated with Moderna/Pfizer vaccine
Vascular complications with dermal evidence (livedo-like, acro-ischemia, necrosis, thromboembolization, chilblain-like eruptions, and petechial/purpuric lesions)	Yes	Yes
Maculopapular eruptions (morbilliform, plaques, and pityriasis rosea-like eruption)	Yes	Yes
Vesicular eruption (vesicle, bullous, chicken-pox-like, and herpes zoster)	Yes	Yes
Erythema (multiformae-like rash, Sweet's syndrome, palmar, and perifollicular)	Yes
Mucosal lesions (enanthema)	Yes
Injection site rash/reaction/urticarial		Yes
Intertriginous or flexural erythema rash	Yes